Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease

Stephens, S., Botteman, M.F., Cifaldi, M.A. et al. (1 more author) (2015) Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease. BMJ Open, 5 (6). ARTN e006560. ISSN 2044-6055

Abstract

Metadata

Authors/Creators:
  • Stephens, S.
  • Botteman, M.F.
  • Cifaldi, M.A.
  • van Hout, B.A.
Copyright, Publisher and Additional Information: This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Keywords: Rheumatoid arthritis; biological therapy; cost-effectiveness; disease-modifying antirheumatic drugs; methotrexate
Dates:
  • Published: 9 June 2015
  • Accepted: 20 March 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 01 Aug 2016 11:39
Last Modified: 01 Aug 2016 11:39
Published Version: https://dx.doi.org/10.1136/bmjopen-2014-006560
Status: Published
Publisher: BMJ Publishing Group
Refereed: Yes
Identification Number: https://doi.org/10.1136/bmjopen-2014-006560
Related URLs:

Share / Export

Statistics